Evaluation of Meibomian Glands in Obstructive Sleep Apnea-Hypopnea Syndrome

dc.contributor.author Muhafiz, Ersin
dc.contributor.author Olcen, Merhamet
dc.contributor.author Erten, Remzi
dc.contributor.author Bozkurt, Erdinc
dc.date.accessioned 2025-05-10T17:09:11Z
dc.date.available 2025-05-10T17:09:11Z
dc.date.issued 2020
dc.description Bozkurt, Erdinc/0000-0002-5570-799X; Erten, Remzi/0000-0001-7775-5792 en_US
dc.description.abstract Purpose: To evaluate the effect of obstructive sleep apnea-hypopnea syndrome (OSAHS) on the meibomian glands, ocular surface, and tear parameters. Methods: The study included 59 individuals (32 subjects with OSAHS, 27 control subjects) who underwent polysomnography in the Chest Diseases Clinic. The right eyes of all individuals were evaluated in the Ophthalmology Clinic. The first noninvasive tear break-up time (f-NTBUT) and the average noninvasive tear break-up time were measured, and Schirmer test was applied. Meibography was taken (Sirius; CSO, Florence, Italy), and meiboscore was used for indexing meibography. Finally, a sample was taken for conjunctival impression cytology. Results: In the study and control groups, the median of f-NTBUT was 2.1 seconds [interquartile range (IQR); 1.5-5.0] and 5.7 seconds (IQR; 2.9-8.8) and the median of average noninvasive tear break-up time was 5.6 seconds (IQR; 3.6-9.5) and 7.2 seconds (IQR; 4.2-10.7), respectively (P= 0.007 andP= 0.487, respectively). The mean Schirmer value was 16.3 +/- 5.9 mm (range; 5-25) and 17.3 +/- 6.6 mm (range; 5-30) in the study and control groups (P= 0.604). In upper eyelid meibography, the median of loss in the meibomian glands was 20.10% (IQR; 11.60%-40.80%) in the study group and 14.70% (IQR; 10.40%-21.30%) in the control group (P= 0.043). In lower eyelid meibography, the median of loss in the meibomian glands was 19.00% (IQR; 13.60%-35.30%) in the study group and 12.40% (IQR; 9.10%-16.40%) in the control group (P= 0.002). The median of the Nelson grade in conjunctival impression cytology was 1 (IQR; 0-1) in the study group and 1 (IQR; 0-1) in the control group (P= 0.445). Conclusions: The loss in the meibomian glands together with the shortened f-NTBUT shows that there could be a predisposition in OSAHS for evaporative dry eye originating from meibomian gland damage. en_US
dc.identifier.doi 10.1097/ICO.0000000000002252
dc.identifier.issn 0277-3740
dc.identifier.issn 1536-4798
dc.identifier.scopus 2-s2.0-85084271819
dc.identifier.uri https://doi.org/10.1097/ICO.0000000000002252
dc.identifier.uri https://hdl.handle.net/20.500.14720/7074
dc.language.iso en en_US
dc.publisher Lippincott Williams & Wilkins en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Osahs en_US
dc.subject Meibomian Glands en_US
dc.subject Meibography en_US
dc.subject Tear Functions en_US
dc.subject Impression Cytology en_US
dc.title Evaluation of Meibomian Glands in Obstructive Sleep Apnea-Hypopnea Syndrome en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Bozkurt, Erdinc/0000-0002-5570-799X
gdc.author.id Erten, Remzi/0000-0001-7775-5792
gdc.author.scopusid 55964654600
gdc.author.scopusid 57216677059
gdc.author.scopusid 24461417500
gdc.author.scopusid 56650731100
gdc.author.wosid Bozkurt, Erdinc/Aaf-9508-2021
gdc.author.wosid Erten, Remzi/V-5175-2019
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Muhafiz, Ersin; Bozkurt, Erdinc] Kafkas Univ, Dept Ophthalmol, Fac Med, Kars, Turkey; [Olcen, Merhamet] Sanliurfa Training & Res Hosp, Dept Chest Dis, Sanliurfa, Turkey; [Erten, Remzi] Van Yuzuncu Yil Univ, Dept Pathol, Fac Med, Van, Turkey en_US
gdc.description.endpage 690 en_US
gdc.description.issue 6 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage 685 en_US
gdc.description.volume 39 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.pmid 31939920
gdc.identifier.wos WOS:000571785000006
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files